Accepted at 11:43 p.m. Oct, 31, 2023 by Ahmed7
Author: ChetLow
Related Note: 1495735525371
Rationale for change

feels more familiar?

Text Text
Extra
This prevents signal transmission through growth (PI3K and MAPK) pathways


Photo credit: Maron SB, Xu J and Janjigian YY (2020) Targeting EGFR in Esophagogastric Cancer. Front. Oncol. 10:553876. doi: 10.3389/fonc.2020.553876
an arrow and word Trastuzumab were added to the image.
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Monoclonal Antibody Therapy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Cellular Injury and Neoplasia : Cell Cycle Independent Drug Targets

Watch associated Bootcamp video - Esophageal and Gastric Pathology : Malignant Gastric Pathology

Watch associated Bootcamp video - Principles of Oncology and Therapeutics : Cell Cycle Independent Drug Targets
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy::zanki_extra #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Trastuzumab #AK_Step1_v12::#OME_banner #AK_Step1_v12::^Other::^EXPN AnkiHub_ImageReady::Text #AK_Step1_v12::#UWorld::Step::6540 #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::k4amjk !AK_UpdateTags::^temporary::ImageFix::11::done #AK_Step1_v12::#UWorld::#UWSA1 #AK_Step1_v12::#AMBOSS::R4alQk #AK_Original_Decks::Step_1::Zanki_Pharmacology AnkiHub_ImageReady::Extra !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#Bootcamp::Gastroenterology::05_Esophageal_and_Gastric_Pathology::07_Malignant_Gastric_Pathology #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::26_Trastuzumab